
H3B-8800
CAS No. 1825302-42-8
H3B-8800( H3B8800 )
Catalog No. M12816 CAS No. 1825302-42-8
H3B-8800 is an orally available splicing modulator that targets spliceosome SF3b complex.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 348 | In Stock |
![]() ![]() |
5MG | 698 | In Stock |
![]() ![]() |
25MG | 1780 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameH3B-8800
-
NoteResearch use only, not for human use.
-
Brief DescriptionH3B-8800 is an orally available splicing modulator that targets spliceosome SF3b complex.
-
DescriptionH3B-8800 is an orally available splicing modulator that targets spliceosome SF3b complex containing either WT or mutant SF3B1 (binding IC50 of 0.3-2 nM); demonstrates dose-dependent inhibition of both canonical splicing and aberrant splicing induced by mutant SF3B1 in in vitro assays of biochemical splicing, induces lethality in spliceosome-mutant cancer cells.Blood Cancer Phase 1 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsH3B8800
-
PathwayOthers
-
TargetSpliceosome
-
RecptorSpliceosome
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1825302-42-8
-
Formula Weight555.716
-
Molecular FormulaC31H45N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(N1CCN(C)CC1)O[C@H]([C@](C)(O)CC[C@@H](O)C2)/C=C/[C@H](C)[C@@H](/C(C)=C/C=C/[C@H](C3=NC=CC=C3)C)OC2=O
-
Chemical Name(2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl 4-methylpiperazine-1-carboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Seiler M, et al. Nat Med. 2018 Feb 19. doi: 10.1038/nm.4493.
2. Finci LI, et al. Genes Dev. 2018 Feb 1;32(3-4):309-320.
3. Cancer Discov. 2018 Mar 2. doi: 10.1158/2159-8290.CD-RW2018-038.
molnova catalog



related products